Atlas Trials

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers

Clinical trial NCT02338856 · COMPLETED

Trial details

NCT number
NCT02338856
Sponsor
Yungjin Pharm. Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metabolic Syndrome
Start date
2015-01-01
Primary completion
2015-02-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.